Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline.
- 1 December 2003
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 6 (4)
- https://doi.org/10.1017/S1461145703003663
Abstract
In 169 depressed patients randomized to treatment with either fluoxetine or nortriptyline, we examined whether polymorphisms of the serotonin transporter and the G protein β3 subunit influenced response to these antidepressants. For depressed patients under the age of 25 yr the T allele of the G protein β3 subunit was associated with a markedly poorer response to nortriptyline, while serotonin transporter polymorphisms did not predict antidepressant response. However, in patients 25 yr or older, the G protein β3 polymorphisms did not predict antidepressant response, while the s,s genotype of the serotonin transporter was associated with a poorer response to both fluoxetine and nortriptyline. These differential pharmacogenetic predictors of antidepressant response by age, may provide clues to understanding the discontinuities in pharmacological responsiveness of child/adolescent and adult depressive disorders.Keywords
This publication has 0 references indexed in Scilit: